You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,248,229


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,248,229
Title:Packaging system for oxygen-sensitive drugs
Abstract: Described herein are pharmaceutical packaging systems which prevent oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive drugs, such systems including a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with very low permeability to oxygen and comprises ethylene vinyl, and an oxygen absorber.
Inventor(s): Devouassoux; Thomas (Saint Martin D'Heres, FR), Forat; Eric (Lyons, FR), Proctor; James Kenneth (Nashville, NC)
Assignee: Becton, Dickinson France S.A.S. (Le Pont De Claix, FR)
Application Number:14/207,207
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,248,229
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,248,229: A Comprehensive Analysis

Introduction

Patents are a crucial component of intellectual property, providing inventors and innovators with exclusive rights to their inventions. The United States Patent 9,248,229, like any other patent, has a specific scope and set of claims that define its boundaries and protections. This article will delve into the details of this patent, exploring its claims, the patent landscape, and relevant statistical and procedural contexts.

What is a Patent?

Before diving into the specifics of US Patent 9,248,229, it is essential to understand what a patent is. A patent is a form of intellectual property that gives the owner the right to exclude others from making, using, selling, and importing an invention for a certain period, usually 20 years from the filing date[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO plays a critical role in the patent process, from application to grant, and ensures that patents meet the criteria of novelty, non-obviousness, and usefulness[2].

Patent 9,248,229: Overview

To analyze the scope and claims of US Patent 9,248,229, one must first identify the patent's title, inventors, filing date, and the technology field it belongs to. However, since the specific details of this patent are not provided in the sources, we will discuss the general process and key elements that would be involved.

Title and Inventors

The title of the patent provides a brief description of the invention, while the inventors are the individuals who created the invention. This information is crucial for understanding the context and purpose of the patent.

Filing Date and Grant Date

The filing date marks the beginning of the patent application process, and the grant date is when the patent is officially issued. These dates are important for determining the patent's term and any prior art considerations.

Technology Field

Patents are categorized into various technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and others. This classification helps in understanding the broader landscape in which the patent operates[1].

Claims of a Patent

The claims section of a patent is the most critical part, as it defines the scope of the invention and what is protected.

Independent and Dependent Claims

Patents typically include both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Claim Construction

The construction of claims involves interpreting the language used to ensure clarity and specificity. This process is crucial for determining the patent's scope and for legal purposes, such as in patent litigation[5].

Patent Scope and Landscape

Patent Scope Measurements

The USPTO has developed measures to quantify patent scope, including detailed information on claims from US patents and applications. These measures help in understanding the breadth and depth of a patent's protection[3].

Technology Trends

The patent landscape is influenced by broader technology trends. For example, electrical engineering patents have significantly increased, driven by advancements in information and communication technologies (ICT)[4].

Statistical Analysis

Allowance Rates

The probability of receiving a US patent can be analyzed through various allowance rates, such as the first-action allowance rate, progenitor allowance rate, and family allowance rate. These rates provide insights into the likelihood of a patent being granted based on different criteria[1].

Patent Applications and Grants

The number of patent applications and grants can indicate the activity level in a particular technology field. For instance, electrical and mechanical engineering patents made up about 60% of USPTO patents in 2018[4].

Procedural Context

Patent Application Process

The patent application process involves several stages, including filing, examination, and potential continuation procedures. Understanding these steps is essential for navigating the patent system[1].

Patent Litigation and Review

Patents can be challenged through various legal proceedings, such as inter partes review (IPR). These processes ensure that patents are valid and do not infringe on prior art[5].

Case Study: Inter Partes Review

The case of Arbutus Biopharma Corporation v. Moderna Therapeutics, Inc. illustrates the complexities of patent litigation. Here, the Patent Trial and Appeal Board (PTAB) found certain claims of a patent to be anticipated by prior art, leading to their invalidation. This case highlights the importance of thorough claim construction and the role of prior art in patent validity[5].

Key Takeaways

  • Patent Claims: The claims section is the heart of a patent, defining what is protected and the scope of the invention.
  • Technology Field: Understanding the technology field helps in placing the patent within the broader innovation landscape.
  • Allowance Rates: Statistical analysis of allowance rates provides insights into the likelihood of a patent being granted.
  • Procedural Context: Knowing the patent application process and potential legal challenges is crucial for patent holders.
  • Patent Scope Measurements: Quantifying patent scope helps in assessing the breadth and depth of protection.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the scope of the invention and specify what is protected by the patent.

How does the USPTO categorize patents into technology fields?

The USPTO categorizes patents into broad technology fields such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and others, using classification schemes like the NBER classification[1].

What is the significance of allowance rates in patent analysis?

Allowance rates, such as first-action allowance rate and family allowance rate, indicate the likelihood of a patent being granted and provide insights into the patent examination process[1].

How can a patent be challenged legally?

A patent can be challenged through legal proceedings such as inter partes review (IPR), where the Patent Trial and Appeal Board (PTAB) reviews the validity of the patent claims[5].

What role does the USPTO play in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that patents meet the criteria of novelty, non-obviousness, and usefulness[2].

Sources

  1. Carley, M., & Hegde, D. What Is the Probability of Receiving a US Patent? Emory Law Journal, 58, 101-107.
  2. USA.gov U.S. Patent and Trademark Office (USPTO)
  3. USPTO Patent Claims Research Dataset
  4. NSF Invention: U.S. and Comparative Global Trends
  5. CAFC Arbutus Biopharma Corporation v. Moderna Therapeutics, Inc.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,248,229

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-006 Jan 16, 2020 AP RX Yes Yes 9,248,229 ⤷  Subscribe Y ⤷  Subscribe
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-007 Feb 10, 2017 AP RX Yes Yes 9,248,229 ⤷  Subscribe Y ⤷  Subscribe
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-003 Apr 30, 2009 AP RX Yes Yes 9,248,229 ⤷  Subscribe Y ⤷  Subscribe
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-004 Apr 30, 2009 AP RX Yes Yes 9,248,229 ⤷  Subscribe Y ⤷  Subscribe
Fresenius Kabi Usa DILAUDID hydromorphone hydrochloride INJECTABLE;INJECTION 019034-005 Apr 30, 2009 AP RX Yes Yes 9,248,229 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.